Kari Wisinski, MD
University of Wisconsin, Madison
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kari Wisinski, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:56 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07706179 · Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast CancerUniversity of Wisconsin, Madison · not yet recruiting · HR+/HER2+ Breast Cancer, Metastatic Breast Cancer · principal investigator
- Early Ph1NCT04174352 · FES Imaging to Optimize Tamoxifen for Metastatic Breast CancerUniversity of Wisconsin, Madison · recruiting · ERα+ Breast Cancer, ESR1 Gene Mutation · principal investigator
- Ph1/Ph2NCT03911973 · Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast CancersKari Wisinski · active not recruiting · TNBC - Triple-Negative Breast Cancer · principal investigator
- Ph2NCT03733119 · ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast CancerUniversity of Wisconsin, Madison · terminated · Triple Negative Breast Cancer · principal investigator
- Ph2NCT03301350 · Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast CancerUniversity of Wisconsin, Madison · completed · Breast Cancer, Triple Negative Breast Cancer · principal investigator
- Ph2NCT03186937 · A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast CancerUniversity of Wisconsin, Madison · terminated · Breast Cancer, Triple Negative Breast Cancer · principal investigator
- Ph1/Ph2NCT03090165 · Ribociclib and Bicalutamide in AR+ TNBCKari Wisinski · active not recruiting · Triple Negative Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.